(NU/1604) The Provision of Services for DNA Methylation Arrays

The Newcastle University Biosciences Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. Our mission is to unravel the basic biological processes and tackle major biomedical challenges, generating knowledge that is vital to human health and educating the next generation of bio-scientists. The Institute is composed of bioengineers and cellular, molecular and computational biologists, working closely together with clinical and technological experts. Our research income is in excess of £11M per year, split over 62 projects from a variety of funding sources including UK charities, Research Councils, UK industry, EU (both industry and government).

The Osteoarthritis Genetics Group, or the OAG, are based within the Biosciences Institute at the International Centre for Life. Their research focus is identifying and characterising those genes that confer risk towards the development and progression of osteoarthritis (OA), research focus is identifying and then characterising those genes that confer risk towards the development and progression of osteoarthritis (OA). The purpose of this tender process is to engage a supplier to run Illumina EPIC methylation arrays on 600 supplied DNA samples. Samples will be supplied for processing in 2 batches in mid-2021.